Monday 8 June 2026

One To Watch

Octapharma

A privately-owned human proteins manufacturer headquartered in Lachen, Switzerland.

Company Overview

Want to Update your Company's Profile?


Latest Octapharma News

Octapharma updates on Balfaxar
13 August 2024
FDA approves new indication for fibryga
6 August 2024
FDA green light for Octapharma's Balfaxar
26 July 2023
Swiss firm spreads tentacles with US rare disease approval
8 December 2021
More Octapharma news >


Today's issue

FDA approves new indication for Pfizer’s Hympavzi
Biotechnology
FDA approves new indication for Pfizer’s Hympavzi
8 June 2026
Pharmaceutical
AdvanCell strengthens executive leadership
8 June 2026
Biotechnology
Sanofi expands AI ambitions through new Owkin collaboration
8 June 2026
Pharmaceutical
MannKind highlights wider role for Afrezza at ADA 2026
8 June 2026
Pharmaceutical
A missing perspective: the burden of skin disease in women
8 June 2026
Biotechnology
Engitix inks collaboration with GSK for liver fibrosis drugs
8 June 2026
Pharmaceutical
Boehringer obesity drug shows fat loss gains but tolerability clouds ADA readout
8 June 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze